Physician
Zaheer, Saadia
Zaheer, Saadia was paid $5.94M by Medicaid between Jan 2018 and Dec 2024, across 74 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 44% of everything it billed.
33Billing provider infoZAHEER, SAADIA
KANKAKEE, IL 60901
KANKAKEE, IL 60901
33aNPI1629178264assigned 09/24/2006
33bProvider typePediatrics Physician
28Total paid$5.94M
24GClaims175,902
24DCodes billed74
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Illinois
Rank by total paid#7 of 1,805
Median peer was paid$55K
This provider vs. median108×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,324 | $546K | |
| 2019 | 22,632 | $690K | |
| 2020 | 16,517 | $495K | |
| 2021 | 25,466 | $869K | |
| 2022 | 35,531 | $1.27M | |
| 2023 | 30,581 | $1.07M | |
| 2024incomplete | 27,851 | $1.00M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 44% | 34,250 | 25,887 | $2.59M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.9% | 7,491 | 6,152 | $348K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.7% | 9,728 | 8,080 | $338K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.3% | 4,209 | 3,591 | $316K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.7% | 4,102 | 3,464 | $280K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.3% | 12,182 | 7,806 | $258K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.2% | 3,346 | 3,009 | $250K |
| 87999 | 3.3% | 2,389 | 1,742 | $195K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.2% | 12,541 | 10,126 | $192K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.1% | 2,216 | 1,972 | $183K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.2% | 5,694 | 5,125 | $133K |
| 96127 | 1.9% | 5,030 | 4,288 | $110K |
62 more codes
| 96112 | 1.2% | 878 | $70K | |
| 83655 | 1.1% | 5,672 | $65K | |
| 92587 | 1.0% | 4,629 | $62K | |
| 36416 | <1% | 10,207 | $41K | |
| 99173 | <1% | 4,830 | $36K | |
| 92558 | <1% | 3,118 | $35K | |
| 90670 | <1% | 2,854 | $34K | |
| 90677 | <1% | 525 | $32K | |
| 99381 | <1% | 325 | $29K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,754 | $27K |
| 85018 | <1% | 11,789 | $27K | |
| 87807 | <1% | 2,466 | $24K | |
| 90698 | <1% | 2,072 | $21K | |
| 90680 | <1% | 1,907 | $21K | |
| 90633 | <1% | 1,939 | $20K | |
| 90686 | <1% | 1,940 | $19K | |
| 90619 | <1% | 659 | $17K | |
| 96160 | <1% | 1,146 | $17K | |
| 90744 | <1% | 1,427 | $15K | |
| 90651 | <1% | 695 | $11K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 383 | $10K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 751 | $9K |
| D1206 | Topical application of fluoride varnish | <1% | 335 | $9K |
| 90710 | <1% | 739 | $8K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 101 | $8K |
| 90715 | <1% | 557 | $8K | |
| 81003 | <1% | 3,533 | $7K | |
| 90697 | <1% | 431 | $6K | |
| 90700 | <1% | 441 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 360 | $5K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 52 | $5K |
| 90696 | <1% | 439 | $5K | |
| 90716 | <1% | 246 | $4K | |
| 0071A | <1% | 84 | $4K | |
| 90707 | <1% | 228 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 309 | $3K |
| 0072A | <1% | 53 | $2K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 15 | $2K |
| 90734 | <1% | 287 | $2K | |
| 90656 | <1% | 115 | $2K | |
| 99383 | <1% | 19 | $2K | |
| 99382 | <1% | 18 | $2K | |
| 99384 | <1% | 13 | $1K | |
| 92567 | <1% | 86 | $1K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 14 | $1K |
| 90685 | <1% | 154 | $981.81 | |
| 90620 | <1% | 59 | $927.68 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 454 | $803.01 |
| 90648 | <1% | 90 | $779.70 | |
| 92588 | <1% | 19 | $380.64 | |
| 86580 | <1% | 92 | $364.00 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 270 | $353.20 |
| 88720 | <1% | 71 | $308.00 | |
| 90713 | <1% | 14 | $233.94 | |
| 91307 | <1% | 30 | $225.00 | |
| 90381 | <1% | 13 | $217.23 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 16 | $190.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 357 | $33.35 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 26 | $5.98 |
| 96161 | 0% | 346 | $0.00 | |
| 90461 | 0% | 64 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 208 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.